asco 2018: latest developments in non-metastatic & metastatic castration-resistant prostate cancer
Published 6 years ago • 1.4K plays • Length 18:54Download video MP4
Download video MP3
Similar videos
-
1:22
advances in non-metastatic castration-resistant prostate cancer
-
18:01
asco gu 2019: updates on non-metastatic castration-resistant prostate cancer (crpc)
-
17:44
updates on non-metastatic castration-resistant prostate cancer
-
22:16
understanding non metastatic castration resistant prostate cancer with dr. hamilton
-
23:03
metastatic castration resistant prostate cancer: updates from asco 2019
-
5:01
fda d.i.s.c.o.: a new drug approval for non-metastatic castration-resistant prostate cancer
-
21:27
focus on non-metastatic castration resistant prostate cancer
-
6:41
esmo expert report on combination therapy in advanced prostate cancer @ asco gu 2022
-
5:05
castrate resistant, non-metastatic prostate cancer (m0 state) | prostate cancer staging guide
-
8:45
clinical trials in nonmetastatic castration-resistant prostate cancer
-
5:46
metastatic castration-resistant prostate cancer – new learnings and perspectives
-
7:46
treating non-metastatic castrate resistant prostate cancer | ask a prostate expert, mark scholz, md
-
8:54
challenges in treating nonmetastatic castration-resistant prostate cancer
-
22:36
key developments in non-metastatic & metastatic hormone-sensitive prostate cancer
-
11:35
nubeqa - a treatment for non-metastatic castration-resistant prostate cancer
-
8:37
nubeqa treatment option for non-metastatic castration-resistant prostate cancer
-
1:36
fda approves bayer's nubeqa (darolutamide) for non-metastatic castration-resistant prostate cancer
-
1:49
living with non-metastatic castration-resistant prostate cancer (nmcrpc): ron and laurie’s story
-
16:39
metastatic castration resistant prostate cancer (mcrpc) – inroads in improved outcomes